GB8909891D0
(en)
*
|
1989-04-28 |
1989-06-14 |
Riker Laboratories Inc |
Device
|
MY105368A
(en)
*
|
1990-03-02 |
1994-09-30 |
Glaxo Group Ltd |
Inhalation device.
|
GB9004781D0
(en)
*
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
US6536427B2
(en)
*
|
1990-03-02 |
2003-03-25 |
Glaxo Group Limited |
Inhalation device
|
SK280968B6
(sk)
*
|
1990-03-02 |
2000-10-09 |
Glaxo Group Limited |
Balenie medikamentu na použite v inhalačnom prístroji
|
FR2667509B1
(fr)
*
|
1990-10-04 |
1995-08-25 |
Valois |
Inhalateur a poudre, dispositif de conditionnement de microdoses de poudre sous forme de bandes adaptees a etre utilisees dans un inhalateur a poudre, et procede de fabrication de ces bandes.
|
JP3194956B2
(ja)
*
|
1992-09-11 |
2001-08-06 |
グラクソ、グループ、リミテッド |
吸入装置
|
SE9203570D0
(sv)
*
|
1992-11-27 |
1992-11-27 |
Astra Ab |
Inhaler for multiple use
|
US5896855A
(en)
*
|
1992-12-24 |
1999-04-27 |
Rhone-Poulenc Rorer Limited |
Multi dose inhaler apparatus
|
ES2115923T3
(es)
*
|
1992-12-24 |
1998-07-01 |
Rhone Poulenc Rorer Ltd |
Inhaladores.
|
GB9326574D0
(en)
*
|
1993-12-31 |
1994-03-02 |
King S College London |
Dry power inhalers
|
JPH07219571A
(ja)
*
|
1994-01-31 |
1995-08-18 |
Yukihiko Takino |
カラオケ曲目表示装置
|
PT101450B
(pt)
*
|
1994-02-02 |
1999-11-30 |
Hovione Produtos Farmaceuticos |
Novo dispositivo para inalacao
|
CN1195466C
(zh)
*
|
1994-08-30 |
2005-04-06 |
法玛西亚普强公司 |
眼睛治疗装置
|
GB9417399D0
(en)
|
1994-08-30 |
1994-10-19 |
Scherer Corp R P |
Ocular treatment device
|
DE29501527U1
(de)
*
|
1995-02-01 |
1995-03-30 |
Hugo Kern und Liebers GmbH & Co. Platinen- und Federnfabrik, 78713 Schramberg |
Vorrichtung zur Erzeugung inhalierbarer Wirkstoffpartikel
|
US5921237A
(en)
*
|
1995-04-24 |
1999-07-13 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US5622166A
(en)
*
|
1995-04-24 |
1997-04-22 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler delivery system
|
SE9503344D0
(sv)
*
|
1995-09-27 |
1995-09-27 |
Astra Ab |
Inhalation device
|
EA001016B1
(ru)
|
1996-01-03 |
2000-08-28 |
Глаксо Груп Лимитед |
Ингаляционное устройство
|
US5857456A
(en)
*
|
1996-06-10 |
1999-01-12 |
Sarnoff Corporation |
Inhaler apparatus with an electronic means for enhanced release of dry powders
|
US5871010A
(en)
*
|
1996-06-10 |
1999-02-16 |
Sarnoff Corporation |
Inhaler apparatus with modified surfaces for enhanced release of dry powders
|
GB9626233D0
(en)
*
|
1996-12-18 |
1997-02-05 |
Chawla Brinda P S |
Medicament packaging and deliveery device
|
SE9700424D0
(sv)
*
|
1997-02-07 |
1997-02-07 |
Astra Ab |
Powder inhaler
|
US6006747A
(en)
*
|
1997-03-20 |
1999-12-28 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
CA2212430A1
(fr)
*
|
1997-08-07 |
1999-02-07 |
George Volgyesi |
Appareil inhalateur
|
US20060165606A1
(en)
*
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US5954047A
(en)
*
|
1997-10-17 |
1999-09-21 |
Systemic Pulmonary Development, Ltd. |
Methods and apparatus for delivering aerosolized medication
|
US6116238A
(en)
*
|
1997-12-02 |
2000-09-12 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
JP2002535048A
(ja)
*
|
1999-01-22 |
2002-10-22 |
グラクソ グループ リミテッド |
吸入装置
|
GB9905538D0
(en)
|
1999-03-10 |
1999-05-05 |
Glaxo Group Ltd |
A device
|
US6601729B1
(en)
|
1999-03-26 |
2003-08-05 |
Papp Enterprises, Llc |
Automated portable medication radial dispensing apparatus and method using a carrier tape
|
GB9909357D0
(en)
|
1999-04-24 |
1999-06-16 |
Glaxo Group Ltd |
Medicament carrier
|
GB9909354D0
(en)
*
|
1999-04-24 |
1999-06-16 |
Glaxo Group Ltd |
Medicament carrier
|
US20100197719A1
(en)
*
|
1999-05-12 |
2010-08-05 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
US20040002548A1
(en)
*
|
1999-05-12 |
2004-01-01 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
US6730066B1
(en)
|
1999-08-03 |
2004-05-04 |
Pharmacia Ab |
Liquid delivery container
|
GB9925934D0
(en)
|
1999-11-03 |
1999-12-29 |
Glaxo Group Ltd |
Novel apparatus and process
|
US20010029947A1
(en)
*
|
1999-12-17 |
2001-10-18 |
Steve Paboojian |
Receptacles to facilitate the extraction of powders
|
US7171965B2
(en)
*
|
2000-02-01 |
2007-02-06 |
Valois S.A.S. |
Breath actuated dry powder inhaler and tape dose strip
|
GB0004456D0
(en)
*
|
2000-02-26 |
2000-04-19 |
Glaxo Group Ltd |
Medicament dispenser
|
DE10011120A1
(de)
|
2000-03-09 |
2001-09-13 |
Pfeiffer Erich Gmbh & Co Kg |
Spender für Medien
|
AU2001250901A1
(en)
*
|
2000-03-27 |
2001-10-08 |
Dura Pharmaceuticals, Inc. |
Containers for individual doses of an inhalable pharmaceutical
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US20030003057A1
(en)
*
|
2000-07-07 |
2003-01-02 |
Jeffry Weers |
Methods for administering leuprolide by inhalation
|
US7442388B2
(en)
*
|
2000-05-10 |
2008-10-28 |
Weers Jeffry G |
Phospholipid-based powders for drug delivery
|
US8404217B2
(en)
*
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
GB0012465D0
(en)
*
|
2000-05-24 |
2000-07-12 |
Glaxo Group Ltd |
Monitoring method
|
GB0013619D0
(en)
*
|
2000-06-06 |
2000-07-26 |
Glaxo Group Ltd |
Sample container
|
GB0014851D0
(en)
*
|
2000-06-16 |
2000-08-09 |
Glaxo Group Ltd |
Novel pharmaceutical formulation
|
GB0015034D0
(en)
|
2000-06-21 |
2000-08-09 |
Glaxo Group Ltd |
Inhalation device
|
PE20020163A1
(es)
*
|
2000-06-23 |
2002-03-04 |
Norton Healthcare Ltd |
Sistema presurizado de receptaculo para inhalador de medicamento
|
US7080644B2
(en)
*
|
2000-06-28 |
2006-07-25 |
Microdose Technologies, Inc. |
Packaging and delivery of pharmaceuticals and drugs
|
JP2004503338A
(ja)
*
|
2000-07-15 |
2004-02-05 |
グラクソ グループ リミテッド |
薬剤取り出し装置
|
WO2002009674A2
(fr)
*
|
2000-07-28 |
2002-02-07 |
Inhale Therapeutic Systems, Inc. |
Nouveaux procedes et compositions destines a reguler positivement, a rediriger ou a limiter les reponses immunitaires aux peptides, proteines et autres composes bioactifs et aux vecteurs exprimant ces derniers
|
AR032471A1
(es)
|
2000-08-05 |
2003-11-12 |
Glaxo Group Ltd |
Derivado de androstano y solvatos del mismo, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden, procesos para preparar tales derivados, intermediarios utiles en la preparacion de tales derivados, procesos para preparar tales intermediarios, y compuestos inter
|
US6759398B2
(en)
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
WO2002013897A2
(fr)
|
2000-08-14 |
2002-02-21 |
Advanced Inhalation Research, Inc. |
Inhalateur et procede correspondant
|
AUPR020400A0
(en)
*
|
2000-09-19 |
2000-10-12 |
Glaxo Wellcome Australia Ltd |
Inhalation device
|
GB0026647D0
(en)
*
|
2000-10-31 |
2000-12-13 |
Glaxo Group Ltd |
Medicament dispenser
|
US20110301569A1
(en)
|
2001-01-20 |
2011-12-08 |
Gordon Wayne Dyer |
Methods and apparatus for the CVCS
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
DE10111945B4
(de)
*
|
2001-03-13 |
2006-03-09 |
Alexander Christ |
Kapselspender
|
ATE381537T1
(de)
|
2001-03-22 |
2008-01-15 |
Glaxo Group Ltd |
Formanilid-derivative als beta2-adrenorezeptor- agonisten
|
US6766799B2
(en)
*
|
2001-04-16 |
2004-07-27 |
Advanced Inhalation Research, Inc. |
Inhalation device
|
CA2445839A1
(fr)
|
2001-04-30 |
2002-11-07 |
Glaxo Group Limited |
Derives anti-inflammatoires d'androstane 17.beta.-carbothioate ester avec un groupe cyclique en position 17.alpha
|
US20030051728A1
(en)
*
|
2001-06-05 |
2003-03-20 |
Lloyd Peter M. |
Method and device for delivering a physiologically active compound
|
FI20011317A0
(fi)
|
2001-06-20 |
2001-06-20 |
Orion Corp |
Jauheinhalaattori
|
JP2004537377A
(ja)
*
|
2001-08-09 |
2004-12-16 |
グラクソ グループ リミテッド |
製薬組成物を有する吸入装置
|
KR100912324B1
(ko)
|
2001-09-14 |
2009-08-14 |
글락소 그룹 리미티드 |
호흡기 질환 치료용 펜에탄올아민 유도체
|
WO2003024396A2
(fr)
|
2001-09-17 |
2003-03-27 |
Glaxo Group Limited |
Formulations de medicament en poudre seche
|
CA2460904C
(fr)
|
2001-09-19 |
2011-03-22 |
Advent Pharmaceuticals Pty Ltd |
Inhalateur servant a administrer des dosages determines de medicaments en poudre
|
GB0125135D0
(en)
*
|
2001-10-19 |
2001-12-12 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0125134D0
(en)
*
|
2001-10-19 |
2001-12-12 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0125132D0
(en)
*
|
2001-10-19 |
2001-12-12 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0127989D0
(en)
*
|
2001-11-22 |
2002-01-16 |
Glaxo Group Ltd |
Medicament dispensing system
|
GB0130055D0
(en)
*
|
2001-12-14 |
2002-02-06 |
Technology Innovation Ltd |
Medicament packaging
|
SI1458360T1
(sl)
|
2001-12-19 |
2011-08-31 |
Novartis Ag |
Pulmonalno dajanje aminoglikozidov
|
GB0217199D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
EP1467790A1
(fr)
|
2002-01-25 |
2004-10-20 |
Glaxo Group Limited |
Distributeur de medicament
|
GB0201677D0
(en)
*
|
2002-01-25 |
2002-03-13 |
Glaxo Group Ltd |
Medicament dispenser
|
AU2003216401A1
(en)
*
|
2002-03-01 |
2003-09-16 |
Glaxo Group Limited |
Rotary blending apparatus and system
|
EP1490031A1
(fr)
*
|
2002-03-07 |
2004-12-29 |
Vectura Limited |
Formulations a base de particules multiples a fusion rapide pour administration orale
|
GB0205572D0
(en)
*
|
2002-03-09 |
2002-04-24 |
Chawla Brinda P S |
Medicament delivery and packaging
|
WO2003095332A1
(fr)
*
|
2002-03-26 |
2003-11-20 |
Glaxo Group Limited |
Procede de formation d'ensemble stratifie et produits formes selon ce procede
|
GR1004350B
(el)
*
|
2002-03-29 |
2003-09-26 |
|
Συσκευη εισπνοων ξηρης σκονης
|
US20030235538A1
(en)
*
|
2002-04-09 |
2003-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Method for the administration of an anticholinergic by inhalation
|
UA80123C2
(en)
*
|
2002-04-09 |
2007-08-27 |
Boehringer Ingelheim Pharma |
Inhalation kit comprising inhalable powder of tiotropium
|
GB0208608D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Composition
|
GB0208609D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Compositions
|
US7271197B2
(en)
|
2002-04-25 |
2007-09-18 |
Glaxo Group Limited |
Phenethanolamine derivatives
|
EP1497629A1
(fr)
*
|
2002-04-25 |
2005-01-19 |
Glaxo Group Limited |
Systeme de capteur magneto-acoustique et procede associe permettant de detecter des conditions environnementales
|
GB0209526D0
(en)
*
|
2002-04-26 |
2002-06-05 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0209528D0
(en)
*
|
2002-04-26 |
2002-06-05 |
Glaxo Group Ltd |
Medicament dispenser
|
AU2003269872A1
(en)
*
|
2002-05-15 |
2003-12-31 |
Glaxo Group Limited |
Microelectromechanical system and method for determining temperature and moisture profiles within pharmaceutical packaging
|
GB0216831D0
(en)
*
|
2002-07-19 |
2002-08-28 |
Glaxo Group Ltd |
Medicament dispenser
|
US20050268908A1
(en)
*
|
2002-07-25 |
2005-12-08 |
Bonney Stanley G |
Medicament dispenser
|
WO2004011068A1
(fr)
|
2002-07-25 |
2004-02-05 |
Glaxo Group Limited |
Distributeur a medicaments
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0217196D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0217198D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
WO2004024308A1
(fr)
*
|
2002-09-13 |
2004-03-25 |
Glaxo Group Limited |
Systeme de melangeage a revetement
|
GB0221493D0
(en)
*
|
2002-09-17 |
2002-10-23 |
Glaxo Group Ltd |
Method for loading a medicament dispenser with a medicament carrier
|
US6962266B2
(en)
*
|
2002-10-04 |
2005-11-08 |
Ecolab Inc. |
Method and apparatus for using a unit dose dispenser
|
ES2291733T3
(es)
*
|
2002-10-22 |
2008-03-01 |
Glaxo Group Limited |
Compuestos de ariletanolamina medicinales.
|
SI1556342T1
(sl)
|
2002-10-28 |
2008-08-31 |
Glaxo Group Ltd |
Fenetanolaminski derivat za zdravljenje respiratornih bolezni
|
WO2004060260A2
(fr)
*
|
2002-12-18 |
2004-07-22 |
Glaxo Group Limited |
Systeme d'administration de medicament dote d'un embout buccal a event
|
US20040173211A1
(en)
*
|
2003-01-14 |
2004-09-09 |
Boehringer Ingelheim International Gmbh |
Powder inhaler
|
GB0303396D0
(en)
|
2003-02-14 |
2003-03-19 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0303870D0
(en)
*
|
2003-02-20 |
2003-03-26 |
Norton Healthcare Ltd |
Pre-metered dose magazine for breath-actuated dry powder inhaler
|
ATE477193T1
(de)
*
|
2003-03-15 |
2010-08-15 |
Brin Tech Internat Ltd |
Verpackung für arzneimittel
|
DE10317461A1
(de)
|
2003-04-16 |
2004-10-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
|
TWI328009B
(en)
|
2003-05-21 |
2010-08-01 |
Glaxo Group Ltd |
Quinoline derivatives as phosphodiesterase inhibitors
|
SE527069C2
(sv)
|
2003-06-19 |
2005-12-13 |
Mederio Ag |
Förfarande och anordning för administrering av läkemedelspulver
|
GB0315509D0
(en)
|
2003-07-02 |
2003-08-06 |
Meridica Ltd |
Dispensing device
|
GB0316335D0
(en)
*
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Pharmaceutical formulations
|
PE20050250A1
(es)
|
2003-07-17 |
2005-04-08 |
Glaxo Group Ltd |
Antagonistas de los receptores muscarinicos de la acetilcolina
|
GB0317374D0
(en)
|
2003-07-24 |
2003-08-27 |
Glaxo Group Ltd |
Medicament dispenser
|
AR046103A1
(es)
|
2003-10-14 |
2005-11-23 |
Glaxo Group Ltd |
Compuesto de 8-azoniabiciclo [3.2.1] octano,composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos y uso del compuesto para preparar dicha composicion
|
GB2407042B
(en)
*
|
2003-10-17 |
2007-10-24 |
Vectura Ltd |
Inhaler
|
EP1677796A4
(fr)
|
2003-10-17 |
2006-12-27 |
Glaxo Group Ltd |
Antagonistes du recepteur acetylcholine muscarinique
|
GB0324654D0
(en)
*
|
2003-10-22 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0324886D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0324897D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Composition
|
WO2005044187A2
(fr)
*
|
2003-10-28 |
2005-05-19 |
Glaxo Group Limited |
Preparations pharmaceutiques inhalables employant de l'anhydrate de lactose, et methodes d'administration desdites preparations
|
AR046225A1
(es)
|
2003-11-04 |
2005-11-30 |
Glaxo Group Ltd |
Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion
|
SE0303570L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Fukt-känslig medicinsk produkt
|
SE0303270L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Metod för administration av tiotropium
|
CA2547782A1
(fr)
*
|
2003-12-03 |
2005-06-16 |
Microdrug Ag |
Produit medical contenant du tiotropium
|
US7631812B2
(en)
*
|
2003-12-10 |
2009-12-15 |
Williams Troy P |
Foldable transaction card systems
|
GB0329182D0
(en)
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Chemical compounds
|
MXPA06008621A
(es)
*
|
2004-02-06 |
2007-03-27 |
Microdose Technologies Inc |
Empaque de burbujas para usarse con un dispositivo de inhalacion.
|
GB2410947B
(en)
*
|
2004-02-11 |
2008-09-17 |
Cambridge Lab Ltd |
Pharmaceutical compounds
|
JP4825138B2
(ja)
|
2004-02-16 |
2011-11-30 |
グラクソ グループ リミテッド |
薬剤ディスペンサー用カウンター
|
US20090253908A1
(en)
*
|
2004-03-11 |
2009-10-08 |
Glaxo Group Limited |
Novel m3 muscarinic acetylchoine receptor antagonists
|
EP1725564A4
(fr)
|
2004-03-17 |
2007-09-12 |
Glaxo Group Ltd |
Antagonistes du recepteur d'acetylcholine muscarinique m3
|
EP1730104A1
(fr)
|
2004-04-02 |
2006-12-13 |
Glaxo Group Limited |
Processus chimique et nouvelle forme cristalline
|
US7828147B2
(en)
*
|
2004-04-24 |
2010-11-09 |
Inrange Systems, Inc. |
Multi-layer medication carrier
|
JP2007535036A
(ja)
*
|
2004-04-24 |
2007-11-29 |
インレンジ システムズ、インク. |
統合された非連続的な遠隔薬剤管理およびコンプライアンスシステム
|
UY28871A1
(es)
|
2004-04-27 |
2005-11-30 |
Glaxo Group Ltd |
Antagonistas del receptor de acetilcolina muscarinico
|
EP1747219A4
(fr)
|
2004-05-13 |
2010-05-26 |
Glaxo Group Ltd |
Domaine de l'invention antagonistes récepteurs d'acétyle choline muscarinique
|
AR049384A1
(es)
|
2004-05-24 |
2006-07-26 |
Glaxo Group Ltd |
Derivados de purina
|
EP1765405A1
(fr)
|
2004-05-31 |
2007-03-28 |
Laboratorios Almirall, S.A. |
Combinaisons contenant des agents antimuscariniques et des corticost roïdes
|
ES2257152B1
(es)
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
SE530006C2
(sv)
*
|
2004-06-18 |
2008-02-05 |
Mederio Ag |
Inhalator som använder balja
|
SE0401654D0
(sv)
*
|
2004-06-24 |
2004-06-24 |
Astrazeneca Ab |
A support structure for a medicament
|
FR2872798B1
(fr)
*
|
2004-07-09 |
2007-10-05 |
Valois Sas |
Ensemble de blisters pour dispositif d'inhalation
|
GB0418278D0
(en)
|
2004-08-16 |
2004-09-15 |
Glaxo Group Ltd |
Medicament dispenser
|
EP1819388A2
(fr)
*
|
2004-10-06 |
2007-08-22 |
Boehringer Ingelheim International GmbH |
Dispositif de distribution, dispositif de stockage et procede de distribution de poudre
|
JP2008519984A
(ja)
*
|
2004-11-12 |
2008-06-12 |
グラクソ グループ リミテッド |
音響変換器を備えるセンサシステム
|
GB0427853D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Manifold for use in medicament dispenser
|
GB0427858D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Manifold for use in medicament dispenser
|
GB0427856D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Maniflod for use in medicament dispenser
|
US20080125462A1
(en)
*
|
2005-01-11 |
2008-05-29 |
Lois Elizabeth Vernon |
Cinnamate Salts Of A Beta-2 Adrenergic Agonist
|
FR2881117B1
(fr)
*
|
2005-01-25 |
2010-07-30 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
FR2881111B1
(fr)
*
|
2005-01-25 |
2010-07-30 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
FR2881119B1
(fr)
*
|
2005-01-25 |
2010-07-30 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
FR2881118B1
(fr)
*
|
2005-01-25 |
2007-04-20 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
JP2008529773A
(ja)
*
|
2005-02-10 |
2008-08-07 |
グラクソ グループ リミテッド |
医薬製剤に使用するためのラクトース粒子の結晶化方法
|
ES2613391T3
(es)
|
2005-02-10 |
2017-05-24 |
Glaxo Group Limited |
Procedimientos de fabricación de lactosa que utilizan técnicas de preclasificación y formulaciones farmacéuticas formadas a partir de la misma
|
AR053450A1
(es)
|
2005-03-25 |
2007-05-09 |
Glaxo Group Ltd |
Derivados de 3,4-dihidro-pirimido(4,5-d)pirimidin-2-(1h)-ona 1,5,7 trisustituidos como inhibidores de la quinasa p38
|
PE20100737A1
(es)
|
2005-03-25 |
2010-11-27 |
Glaxo Group Ltd |
Nuevos compuestos
|
EP1879579A1
(fr)
*
|
2005-05-04 |
2008-01-23 |
Boehringer Ingelheim International GmbH |
Dispositif d'inhalation contenant plusieurs doses d'une composition pharmaceutique
|
GB0509952D0
(en)
*
|
2005-05-16 |
2005-06-22 |
Glaxo Group Ltd |
Fault indicator
|
ES2265276B1
(es)
|
2005-05-20 |
2008-02-01 |
Laboratorios Almirall S.A. |
Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
|
GB0514501D0
(en)
*
|
2005-07-14 |
2005-08-24 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
GB0514809D0
(en)
|
2005-07-19 |
2005-08-24 |
Glaxo Group Ltd |
Compounds
|
DE102005035705A1
(de)
|
2005-07-27 |
2007-02-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Arzneimittelblister
|
GB0515584D0
(en)
|
2005-07-28 |
2005-09-07 |
Glaxo Group Ltd |
Medicament dispenser
|
EP1937230A4
(fr)
*
|
2005-08-02 |
2009-08-26 |
Glaxo Group Ltd |
Antagonistes du recepteur d'acetylcholine muscarinique m3
|
US20080275079A1
(en)
*
|
2005-08-02 |
2008-11-06 |
Glaxo Group Limited |
M3 Muscarinic Acetylcholine Receptor Antagonists
|
GB0516168D0
(en)
*
|
2005-08-05 |
2005-09-14 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
JP2009504768A
(ja)
|
2005-08-18 |
2009-02-05 |
グラクソ グループ リミテッド |
ムスカリン性アセチルコリン受容体アンタゴニスト
|
TWI274641B
(en)
*
|
2005-08-30 |
2007-03-01 |
Rexon Ind Corp Ltd |
Cutting machine
|
US20070068837A1
(en)
*
|
2005-09-29 |
2007-03-29 |
D Angelis Bruno S |
Wound dressing dispenser
|
GB0521563D0
(en)
|
2005-10-21 |
2005-11-30 |
Glaxo Group Ltd |
Novel compounds
|
AR058289A1
(es)
|
2005-12-12 |
2008-01-30 |
Glaxo Group Ltd |
Colector para ser usado en dispensador de medicamento
|
AR058290A1
(es)
*
|
2005-12-12 |
2008-01-30 |
Glaxo Group Ltd |
Dispensador de medicamento
|
US7987845B2
(en)
|
2006-01-31 |
2011-08-02 |
Oriel Therapeutics, Inc. |
Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods
|
JP5188991B2
(ja)
*
|
2006-03-03 |
2013-04-24 |
エスティーシー.ユーエヌエム |
空力弾性分配メカニズムを有するドライパウダー吸入器
|
US8127763B2
(en)
*
|
2006-03-03 |
2012-03-06 |
Stc.Unm |
Dry powder inhaler with aeroelastic dispersion mechanism
|
GB0605150D0
(en)
*
|
2006-03-14 |
2006-04-26 |
Glaxo Group Ltd |
Counter For Use With A Medicament Dispenser
|
EP1844808A1
(fr)
*
|
2006-04-13 |
2007-10-17 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
Dispositif pour délivrer un médicament
|
EP1844809A1
(fr)
*
|
2006-04-13 |
2007-10-17 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Réservoir d'inhalateur, et inhalateur multi-doses
|
AU2007242851A1
(en)
|
2006-04-20 |
2007-11-01 |
Glaxo Group Limited |
Novel compounds
|
GR1005668B
(el)
*
|
2006-05-09 |
2007-10-02 |
|
Συσκευη εισπνοων ξηρης σκονης για την ταυτοχρονη χορηγηση περισσοτερων απο μιας φαρμακευτικων ουσιων
|
GR1005620B
(el)
*
|
2006-05-09 |
2007-09-03 |
|
Βελτιωση συσκευης εισπνοων ξηρης σκονης
|
DE102006023662A1
(de)
*
|
2006-05-18 |
2007-11-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalator
|
US9457161B2
(en)
|
2006-05-18 |
2016-10-04 |
Boehringer Ingelheim International Gmbh |
Inhaler
|
GB0611587D0
(en)
|
2006-06-12 |
2006-07-19 |
Glaxo Group Ltd |
Novel compounds
|
FR2904229B1
(fr)
*
|
2006-07-25 |
2008-10-10 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
CA2659539A1
(fr)
|
2006-08-01 |
2008-02-07 |
Glaxo Group Limited |
Composes de pyrazolo[3,4-b]pyridine et leur utilisation en tant qu'inhibiteurs de pde4
|
NZ576637A
(en)
|
2006-10-25 |
2012-05-25 |
Novartis Ag |
Powder dispersion apparatus with and mediciment receptacles that are cut open using an elliptical arc shaped knife blade oriented to yaw between 4 and 12 degrees
|
GB0622827D0
(en)
|
2006-11-15 |
2006-12-27 |
Glaxo Group Ltd |
Sheet driver for use in a drug dispenser
|
EP1925295A1
(fr)
|
2006-11-22 |
2008-05-28 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Formule de poudre stable contenant un nouveau anticholinergique
|
WO2008081132A2
(fr)
*
|
2006-12-11 |
2008-07-10 |
Valois Sas |
Dispositif de distribution de produit fluide
|
FR2909643B1
(fr)
*
|
2006-12-11 |
2011-03-04 |
Valois Sas |
Dispositif de distribution de produit fluide
|
US20080163610A1
(en)
*
|
2007-01-05 |
2008-07-10 |
Matthew Thomas Baird |
Method and system for regenerating exhaust system filtering and catalyst components using variable high engine idle
|
ES2306595B1
(es)
|
2007-02-09 |
2009-09-11 |
Laboratorios Almirall S.A. |
Sal de napadisilato de 5-(2-((6-(2,2-difluoro-2-feniletoxi)hexil)amino)-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona como agonista del receptor adrenergico beta2.
|
ES2320955B1
(es)
|
2007-03-02 |
2010-03-16 |
Laboratorios Almirall S.A. |
Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
|
US8616199B2
(en)
|
2007-03-16 |
2013-12-31 |
Canon Kabushiki Kaisha |
Inhaler and ejection head unit attachable to the inhaler
|
AR065804A1
(es)
|
2007-03-23 |
2009-07-01 |
Smithkline Beecham Corp |
Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
|
JP5198801B2
(ja)
*
|
2007-05-30 |
2013-05-15 |
株式会社吉野工業所 |
吸引式投薬器
|
WO2008156586A2
(fr)
*
|
2007-06-12 |
2008-12-24 |
Alkermes, Inc. |
Perfectionnements à des dispositifs inhalateurs de poudre
|
EP2011536A1
(fr)
*
|
2007-07-06 |
2009-01-07 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Inhalateur
|
JP2010532241A
(ja)
*
|
2007-07-06 |
2010-10-07 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
吸入器
|
ES2569359T3
(es)
*
|
2007-07-06 |
2016-05-10 |
Vectura Delivery Devices Limited |
Inhalador
|
ES2320961B1
(es)
|
2007-11-28 |
2010-03-17 |
Laboratorios Almirall, S.A. |
Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor adrenergico beta2.
|
KR20100103834A
(ko)
|
2007-12-20 |
2010-09-28 |
아스트라제네카 아베 |
분말 854를 탈응집하는 장치 및 방법
|
AU2009206801B2
(en)
*
|
2008-01-23 |
2011-07-07 |
Astrazeneca Ab |
A medicament-containing dispenser provided with a display for presenting indicia to a user
|
EP2082758A1
(fr)
*
|
2008-01-24 |
2009-07-29 |
Boehringer Ingelheim International GmbH |
Inhalateur
|
EP2082759A1
(fr)
*
|
2008-01-24 |
2009-07-29 |
Boehringer Ingelheim International GmbH |
Inhalateur
|
EP2082764A1
(fr)
*
|
2008-01-24 |
2009-07-29 |
Boehringer Ingelheim International GmbH |
Inhalateur
|
EP2096105A1
(fr)
|
2008-02-28 |
2009-09-02 |
Laboratorios Almirall, S.A. |
Dérivés de 4-(2-amino-1-hydroxyethyl)phénol en tant qu'antagonistes du récepteur adrénergique b2
|
EP2100599A1
(fr)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques
|
EP2100598A1
(fr)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques
|
EP2108641A1
(fr)
|
2008-04-11 |
2009-10-14 |
Laboratorios Almirall, S.A. |
Nouveaux dérivés substitués de spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one et leur utilisation comme ihibiteurs de p38 mitogen-activated kinase
|
EP2113503A1
(fr)
|
2008-04-28 |
2009-11-04 |
Laboratorios Almirall, S.A. |
Nouveaux dérivés d'indolin-2-one substitués et leur utilisation comme inhibiteurs de p38 mitogen-activated kinase
|
GB0810857D0
(en)
*
|
2008-06-13 |
2008-07-23 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
WO2010008523A1
(fr)
|
2008-07-13 |
2010-01-21 |
Map Pharmaceuticals, Inc. |
Procédés et appareil pour distribuer un médicament en aérosol
|
US20110053866A1
(en)
*
|
2008-08-12 |
2011-03-03 |
Biovail Laboratories International (Barbados) S.R.L. |
Pharmaceutical compositions
|
GB2462611A
(en)
*
|
2008-08-12 |
2010-02-17 |
Cambridge Lab |
Pharmaceutical composition comprising tetrabenazine
|
GB2463283A
(en)
*
|
2008-09-08 |
2010-03-10 |
Cambridge Lab |
3,11b-cis-dihydrotetrabenazine for use in treating asthma
|
GB2463452A
(en)
*
|
2008-09-08 |
2010-03-17 |
Cambridge Lab |
Desmethyl derivatives of tetrabenazine and pharmaceutical compositions thereof
|
GB2463451A
(en)
|
2008-09-08 |
2010-03-17 |
Cambridge Lab |
3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia
|
CN102159270B
(zh)
|
2008-09-26 |
2014-07-02 |
奥里尔治疗公司 |
一种带有具有气道盘沟槽的气道盘的吸入器和相关的气道盘和方法
|
CA2732840C
(fr)
|
2008-09-26 |
2016-07-05 |
Oriel Therapeutics, Inc. |
Inhalateurs de poudre seche pourvus d'organes de percage doubles et dispositifs et procedes associes
|
WO2010036355A2
(fr)
*
|
2008-09-26 |
2010-04-01 |
Oriel Therapeutics, Inc. |
Mécanismes d’inhalateurs avec éperons sollicités radialement et procédés associés
|
US9050427B2
(en)
*
|
2008-09-30 |
2015-06-09 |
Oriel Therapeutics, Inc. |
Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods
|
ES2561899T3
(es)
*
|
2008-10-01 |
2016-03-01 |
Oriel Therapeutics, Inc. |
Inhaladores de polvo seco con mecanismos de perforación giratorios y dispositivos y métodos relacionados
|
WO2010042036A1
(fr)
*
|
2008-10-08 |
2010-04-15 |
Astrazeneca Ab |
Inhalateur doté de moyens d'indication audibles
|
GB201020130D0
(en)
*
|
2010-11-26 |
2011-01-12 |
Vectura Delivery Devices Ltd |
Inhaler
|
EP2196465A1
(fr)
|
2008-12-15 |
2010-06-16 |
Almirall, S.A. |
Dérivés de (3-oxo)pyridazin-4-ylurée comme inhibiteurs de PDE4
|
EP2198908A1
(fr)
*
|
2008-12-19 |
2010-06-23 |
Boehringer Ingelheim International Gmbh |
Inhalateur
|
UY32297A
(es)
|
2008-12-22 |
2010-05-31 |
Almirall Sa |
Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-fenilitoxi) hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2( 1h)-ona como agonista del receptor b(beta)2 acrenérgico
|
BRPI1006162A2
(pt)
|
2009-01-13 |
2019-09-24 |
Glaxo Group Ltd |
"composto,processo para preparar um composto,formulação farmacêutica,e uso de um composto".
|
NZ574666A
(en)
*
|
2009-02-05 |
2009-04-30 |
Nexus6 Ltd |
A medicament inhaler holder that uses optical means to count and display the number of doses used
|
WO2010094643A1
(fr)
|
2009-02-17 |
2010-08-26 |
Glaxo Group Limited |
Dérivés de quinoline et applications associées dans la rhinite et l'urticaire
|
EP2221055A1
(fr)
|
2009-02-18 |
2010-08-25 |
Almirall, S.A. |
5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one pour le traitement de la fonction pulmonaire
|
EP2221297A1
(fr)
|
2009-02-18 |
2010-08-25 |
Almirall, S.A. |
5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one et son utiisation dans le traitement de maladies des voies respiratoires
|
DK2400950T3
(da)
|
2009-02-26 |
2019-07-29 |
Glaxo Group Ltd |
Farmaceutiske formuleringer omfattende 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
|
EP2226323A1
(fr)
|
2009-02-27 |
2010-09-08 |
Almirall, S.A. |
Nouveaux dérivés de tétrahydropyrazolo [3,4-c]isoquinoléine-5-amine
|
EP2228368A1
(fr)
|
2009-03-12 |
2010-09-15 |
Almirall, S.A. |
Procédé de fabrication de 5-(2-{[6-(2,2-difluoro-2-ph2nyl2thoxy)hexyl]amino}-1-hydroxy2thyl)-8-hydroxyquinolin-2(1h)-one
|
UY32571A
(es)
|
2009-04-24 |
2010-11-30 |
Glaxo Group Ltd |
Compuestos derivados de pirazol amida
|
WO2010122088A1
(fr)
|
2009-04-24 |
2010-10-28 |
Glaxo Group Limited |
Pyrazole et triazole carboxamides en tant qu'inhibiteurs du canal crac
|
DE202009006141U1
(de)
|
2009-04-25 |
2009-08-27 |
Boehringer Ingelheim International Gmbh |
Inhalator
|
PT2427166E
(pt)
|
2009-05-07 |
2014-01-20 |
Gea Pharma Systems Ltd |
Módulo de produção de comprimidos e método para a produção contínua de comprimidos
|
ES2506166T3
(es)
|
2009-05-18 |
2014-10-13 |
Norton Healthcare Limited |
Inhalador de polvo seco
|
EP3332826A1
(fr)
|
2009-05-18 |
2018-06-13 |
Adamis Pharmaceuticals Corporation |
Inhalateur de poudre sèche muni d'un compteur de dose
|
PL2432533T3
(pl)
|
2009-05-18 |
2015-11-30 |
Norton Healthcare Ltd |
Inhalator suchego proszku
|
JP5720009B2
(ja)
|
2009-05-18 |
2015-05-20 |
アダミス ファーマシューティカルズ コーポレーション |
ドライパウダー吸入器
|
WO2010136134A1
(fr)
|
2009-05-18 |
2010-12-02 |
Norton Healthcare Limited |
Inhalateur de poudre sèche
|
EP2432536B1
(fr)
*
|
2009-05-21 |
2018-07-04 |
MicroDose Therapeutx, Inc. |
Système de cassette rotative pour inhalateur de poudre sèche
|
US8985101B2
(en)
|
2009-05-21 |
2015-03-24 |
Microdose Therapeutx, Inc. |
Method and device for clamping a blister within a dry powder inhaler
|
JP2012530140A
(ja)
|
2009-06-16 |
2012-11-29 |
メルク・シャープ・アンド・ドーム・コーポレーション |
グルココルチコイド受容体アゴニストとしての新規[3,2−c]ヘテロアリールステロイド、組成物およびこの使用
|
EP2448623B1
(fr)
|
2009-07-01 |
2017-12-20 |
AstraZeneca AB |
Distributeur et procédé d'entraînement de poudre dans un écoulement d'air
|
WO2011129785A1
(fr)
*
|
2010-04-13 |
2011-10-20 |
Mahmut Bilgic |
Bouton d'embout buccal pour inhalateur à poudre sèche
|
GB0919431D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
AU2010314395B2
(en)
|
2009-11-05 |
2015-04-09 |
Glaxosmithkline Llc |
Benzodiazepine bromodomain inhibitor
|
EP3050885B1
(fr)
|
2009-11-05 |
2017-10-18 |
GlaxoSmithKline LLC |
Inhibiteur de bromodomain vis-a-vis de la benzodiazepine
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
GB0919426D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
GB0919423D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
WO2011054851A1
(fr)
|
2009-11-05 |
2011-05-12 |
Glaxosmithkline Llc |
Nouveau procédé
|
EP2322176A1
(fr)
|
2009-11-11 |
2011-05-18 |
Almirall, S.A. |
Nouveaux dérivés de 7-phényl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one
|
EP2498848A2
(fr)
|
2009-11-12 |
2012-09-19 |
Stc.Unm |
Inhalateur pour poudre sèche avec un élément de dispersion par flottement
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
TR200909791A2
(tr)
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Salmeterol ve flutikazon içeren farmasötik bileşim@
|
WO2011085022A1
(fr)
|
2010-01-05 |
2011-07-14 |
Microdose Therapeutx, Inc. |
Dispositif et procédé d'inhalation
|
US9046403B2
(en)
*
|
2010-02-01 |
2015-06-02 |
Mallinckrodt Llc |
Systems and methods for managing use of a medicament
|
US8490795B2
(en)
|
2010-02-01 |
2013-07-23 |
Mallinckrodt Llc |
Container and method for facilitating disposal of unused pharmaceutical product
|
EP2380890A1
(fr)
|
2010-04-23 |
2011-10-26 |
Almirall, S.A. |
Nouveaux dérivés de 7,8-dihydro-1,6-naphthyridin-5(6h)-one comme PDE4 inhibiteurs
|
GB201007203D0
(en)
|
2010-04-29 |
2010-06-16 |
Glaxo Group Ltd |
Novel compounds
|
EP2386555A1
(fr)
|
2010-05-13 |
2011-11-16 |
Almirall, S.A. |
Nouveaux dérivés de cyclohéxylamine dotés d'activités agoniste bêta 2 adrénergique et antagoniste muscarinique m3
|
EP2394998A1
(fr)
|
2010-05-31 |
2011-12-14 |
Almirall, S.A. |
Dérivés de 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl en tant qu'inhibiteurs de la PDE4
|
FR2961186B1
(fr)
*
|
2010-06-11 |
2012-07-13 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
WO2011161031A1
(fr)
|
2010-06-22 |
2011-12-29 |
Glaxosmithkline Llc |
Composés de benzotriazolodiazépine inhibiteurs de bromodomaines
|
FR2962345B1
(fr)
|
2010-07-09 |
2013-06-21 |
Valois Sas |
Inhalateur unidose de poudre seche pour blister pelable.
|
ES2535701T3
(es)
*
|
2010-07-21 |
2015-05-14 |
Astrazeneca Ab |
Inhalador
|
WO2012025473A1
(fr)
|
2010-08-24 |
2012-03-01 |
Glaxo Group Limited |
Antagonistes du récepteur 4 des chimiokines cc
|
WO2012025474A1
(fr)
|
2010-08-24 |
2012-03-01 |
Glaxo Group Limited |
Composés indazole
|
AU2011298315B2
(en)
|
2010-08-31 |
2014-08-28 |
Glaxo Group Limited |
Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
|
ES2845185T3
(es)
|
2010-08-31 |
2021-07-26 |
Glaxosmithkline Ip Dev Ltd |
Productos farmacológicos para la inhalación de polvo seco que presentan propiedades de control de la humedad y procedimientos de administración de los mismos
|
EP2441755A1
(fr)
|
2010-09-30 |
2012-04-18 |
Almirall, S.A. |
Dérivés de pyridine et isoquinoline comme inhibiteurs des kinases Syk et JAK
|
ES2532213T3
(es)
|
2010-10-21 |
2015-03-25 |
Glaxo Group Limited |
Compuestos de pirazol que actúan contra afecciones alérgicas, inmunitarias e inflamatorias
|
WO2012052459A1
(fr)
|
2010-10-21 |
2012-04-26 |
Glaxo Group Limited |
Composés de pyrazole agissant contre des troubles allergiques, inflammatoires et immunitaires
|
US9297813B2
(en)
|
2010-11-11 |
2016-03-29 |
Agency For Science, Technology And Research |
Targeting metabolic enzymes in human cancer
|
EP2457900A1
(fr)
|
2010-11-25 |
2012-05-30 |
Almirall, S.A. |
Nouveaux dérivés de pyrazole présentant un comportement antagoniste CRTH2
|
EP2463289A1
(fr)
|
2010-11-26 |
2012-06-13 |
Almirall, S.A. |
Dérivés imidazo[1,2-b]pyridazine en tant qu'inhibiteur JAK
|
US8561609B2
(en)
|
2010-12-07 |
2013-10-22 |
Respira Therapeutics, Inc. |
Dry powder inhaler
|
EP2489663A1
(fr)
|
2011-02-16 |
2012-08-22 |
Almirall, S.A. |
Composés en tant qu'inhibiteurs de la syk kinase
|
US20140005188A1
(en)
|
2011-03-11 |
2014-01-02 |
Glaxo Group Limited |
Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
|
GB201104153D0
(en)
|
2011-03-11 |
2011-04-27 |
Glaxo Group Ltd |
Novel compounds
|
US8834411B2
(en)
|
2011-04-06 |
2014-09-16 |
Mystic Pharmaceuticals, Inc. |
Medical devices for dispensing powders
|
EP2510928A1
(fr)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium pour l'amélioration du sommeil des patients avec des maldadies respiratoires
|
GB201106750D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
GB201106799D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
GB201106743D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
EP2518070A1
(fr)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Dérivés de pyrrolotriazinon en tant qu'inhibiteurs PI3K
|
EP2518071A1
(fr)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Dérivés d'imidazopyridine en tant qu'inhibiteurs PI3K
|
GB201107325D0
(en)
|
2011-05-04 |
2011-06-15 |
Glaxosmithkline Llc |
Novel compounds
|
EP2526945A1
(fr)
|
2011-05-25 |
2012-11-28 |
Almirall, S.A. |
Nouveaux antagonistes de CRTH2
|
EP2527344A1
(fr)
|
2011-05-25 |
2012-11-28 |
Almirall, S.A. |
Dérivés de pyridin-2(1h)-one utiles comme médicaments pour le traitement de maladies myeloproliferatives, de rejets de greffe, de maladies a médiation immune et de maladies inflammatoires
|
RU2013153202A
(ru)
|
2011-06-08 |
2015-07-20 |
Глаксо Груп Лимитед |
Композиции для ингалятора сухого порошка, содержащие умеклидиний
|
PE20141048A1
(es)
|
2011-06-08 |
2014-09-08 |
Glaxo Group Ltd |
Combinacion que comprende umeclidinio y un corticosteroide
|
EP2548863A1
(fr)
|
2011-07-18 |
2013-01-23 |
Almirall, S.A. |
Nouveaux antagonistes de CRTH2
|
EP2548876A1
(fr)
|
2011-07-18 |
2013-01-23 |
Almirall, S.A. |
Nouveaux antagonistes de CRTH2
|
EP2554544A1
(fr)
|
2011-08-01 |
2013-02-06 |
Almirall, S.A. |
Dérivés de pyridin-2(1h)-one en tant qu'inhibiteurs de JAK
|
GB201114103D0
(en)
|
2011-08-17 |
2011-09-28 |
Glaxosmithkline Llc |
Novel compounds
|
GB201116641D0
(en)
|
2011-09-27 |
2011-11-09 |
Glaxo Group Ltd |
Novel compounds
|
EP2578570A1
(fr)
|
2011-10-07 |
2013-04-10 |
Almirall, S.A. |
Nouveau procédé de fabrication de 5-(2-{[6-(2,2-difluoro-2-phényléthoxy)hexyl]amino}-1-hydroxyéthyl)-8-hydroxyquinolin-2(1h)-one via de nouveaux intermédiaires de synthèse
|
EP2592077A1
(fr)
|
2011-11-11 |
2013-05-15 |
Almirall, S.A. |
Nouveaux dérivés de cyclohéxylamine dotés d'activités agonistes bêta 2 adrénergique et antagoniste muscarinique M3
|
EP2592078A1
(fr)
|
2011-11-11 |
2013-05-15 |
Almirall, S.A. |
Nouveaux dérivés de cyclohéxylamine dotés d'activités agonistes bêta 2 adrénergique et antagoniste muscarinique M3
|
WO2013114371A1
(fr)
|
2012-02-01 |
2013-08-08 |
Protalix Ltd. |
Formulation en poudre sèche de dnase i
|
US10463815B2
(en)
|
2012-02-21 |
2019-11-05 |
Respira Therapeutics, Inc. |
Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
|
GB2499597A
(en)
*
|
2012-02-21 |
2013-08-28 |
Innovata Biomed Ltd |
Dry powder inhaler with stepped rotation of metering member
|
EP2641900A1
(fr)
|
2012-03-20 |
2013-09-25 |
Almirall, S.A. |
Nouvelles formes polymorphes de héminapadisylate de 5-(2-{[6-(2,2-difluoro-2-phényléthoxy) hexyl]amino}-1-(R)-hydroxyéthyl)-8-hydroxyquinolin-2(1h)-one en tant qu'agoniste du récepteur adrénergique ß2
|
EP2647627A1
(fr)
|
2012-04-02 |
2013-10-09 |
Almirall, S.A. |
Sels de 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phényléthoxy)phényl]éthyl}amino)- 1-hydroxyéthyl]-8- hydroxyquinolin-2(1h)-one
|
DE102012104850A1
(de)
|
2012-04-05 |
2013-10-10 |
Alfred Von Schuckmann |
Vorrichtung zur portionierten Ausgabe von Medikamenten
|
KR20140147891A
(ko)
|
2012-04-13 |
2014-12-30 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
응집체 입자
|
GB201207406D0
(en)
|
2012-04-27 |
2012-06-13 |
Glaxo Group Ltd |
Novel compounds
|
AR090847A1
(es)
|
2012-04-27 |
2014-12-10 |
Glaxo Group Ltd |
Compuestos moduladores del receptor huerfano retinoideo (ror)
|
EP2662105B1
(fr)
|
2012-05-09 |
2017-01-18 |
Boehringer Ingelheim International GmbH |
Pulvérisateur
|
FR2990872B1
(fr)
*
|
2012-05-24 |
2015-05-15 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
EP2666465A1
(fr)
|
2012-05-25 |
2013-11-27 |
Almirall, S.A. |
Nouveau dosage et formule
|
WO2013176639A1
(fr)
*
|
2012-05-25 |
2013-11-28 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Dispositif inhalateur pourvu d'un mécanisme d'avance amélioré de plaquette alvéolaire
|
EA201492044A1
(ru)
*
|
2012-05-25 |
2015-05-29 |
Арвен Айлак Санайи Ве Тиджарет А.С. |
Ингалятор, содержащий внутренний корпус, имеющий канал для воздуха
|
GB2502350A
(en)
|
2012-05-25 |
2013-11-27 |
Vectura Delivery Devices Ltd |
Inhaler having means to control the force applied to an actuating lever
|
EP2668941A1
(fr)
|
2012-05-31 |
2013-12-04 |
Almirall, S.A. |
Nouveau dosage et formulation d'abediterol
|
WO2014006135A2
(fr)
|
2012-07-05 |
2014-01-09 |
Glaxo Group Limited |
Dispositif inhalateur
|
WO2014060431A1
(fr)
|
2012-10-16 |
2014-04-24 |
Almirall, S.A. |
Dérivés de pyrrolotriazinone en tant qu'inhibiteurs des pi3k
|
EP2738172A1
(fr)
|
2012-11-28 |
2014-06-04 |
Almirall, S.A. |
Nouveaux composés bicycliques utilisés comme modulateurs du canal crac
|
CN104853758A
(zh)
|
2012-11-28 |
2015-08-19 |
英特赛普特医药品公司 |
肺部疾病的治疗
|
JP5350530B1
(ja)
*
|
2012-12-07 |
2013-11-27 |
ニップファーマ株式会社 |
薬剤吸入デバイス
|
AU2013360866A1
(en)
|
2012-12-18 |
2015-07-02 |
Almirall, S.A. |
New cyclohexyl and quinuclidinyl carbamate derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activity
|
TW201446767A
(zh)
|
2013-02-15 |
2014-12-16 |
Almirall Sa |
作為磷脂肌醇3-激酶抑製劑之吡咯並三嗪衍生物
|
UA118549C2
(uk)
|
2013-03-14 |
2019-02-11 |
Ґлаксосмітклайн Інтеллекчуал Проперті (№ 2) Лімітед |
2,3-дизаміщені похідні 1-ацил-4-аміно-1,2,3,4-тетрагідрохіноліну та їх застосування як інгібіторів бромодомену
|
CA2903357A1
(fr)
|
2013-03-14 |
2014-09-18 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Furanopyridines en tant qu'inhibiteurs de bromodomaines
|
GB201305668D0
(en)
|
2013-03-28 |
2013-05-15 |
Glaxosmithkline Ip Dev Ltd |
Avs6 Integrin Antagonists
|
JP6105373B2
(ja)
*
|
2013-04-25 |
2017-03-29 |
株式会社吉野工業所 |
吸引器具
|
JP5985434B2
(ja)
*
|
2013-04-25 |
2016-09-06 |
株式会社吉野工業所 |
吸引器具
|
RU2544801C2
(ru)
*
|
2013-06-11 |
2015-03-20 |
Открытое Акционерное Общество "Фармацевтическая Фабрика Санкт-Петербурга" |
Порошковый ингалятор
|
EP2848615A1
(fr)
|
2013-07-03 |
2015-03-18 |
Almirall, S.A. |
Nouveaux dérivés de pyrazole utilisés comme modulateurs du canal CRAC
|
USD737425S1
(en)
|
2013-07-09 |
2015-08-25 |
Celon Pharma S.A. |
Inhaler
|
USD759163S1
(en)
|
2013-07-30 |
2016-06-14 |
Celon Pharma S.A. |
Label for an inhaler
|
USD746378S1
(en)
|
2013-07-30 |
2015-12-29 |
Celon Pharma S.A. |
Label for an inhaler
|
CN103624401B
(zh)
*
|
2013-08-20 |
2016-03-02 |
南京理工大学 |
立式定量控制的自动爆炸复合炸药铺放装置
|
WO2015091285A1
(fr)
|
2013-12-19 |
2015-06-25 |
Almirall S.A. |
Formulation de dosage comprenant du salmétérol et du propionate de fluticasone
|
CN106061532A
(zh)
|
2013-12-23 |
2016-10-26 |
格兰马克药品有限公司 |
干粉吸入器
|
KR20170003673A
(ko)
|
2014-05-12 |
2017-01-09 |
글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 |
감염성 질환을 치료하기 위한 다니릭신을 포함하는 약제 조성물
|
WO2015181262A1
(fr)
|
2014-05-28 |
2015-12-03 |
Glaxosmithkline Intellectual Property Development Limited |
Furoate de fluticasone utilisé dans le traitement de la bpco
|
EP2957552B1
(fr)
|
2014-06-16 |
2020-01-22 |
Arven Ilac Sanayi Ve Ticaret A.S. |
Formulations de vilanterol
|
EP2957553A1
(fr)
|
2014-06-16 |
2015-12-23 |
Arven Ilac Sanayi Ve Ticaret A.S. |
Formulations pharmaceutiques de vilanterol
|
EP2957550A1
(fr)
|
2014-06-16 |
2015-12-23 |
Arven Ilac Sanayi Ve Ticaret A.S. |
Formulations pharmaceutiques comprenant du vilanterol
|
TR201407010A2
(tr)
|
2014-06-16 |
2015-12-21 |
Arven Ilac Sanayi Ve Ticaret Anonim Sirketi |
Vilanterol formülasyonları.
|
US20170304459A1
(en)
|
2014-10-10 |
2017-10-26 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for inhalation delivery of conjugated oligonucleotide
|
US9550032B2
(en)
*
|
2014-10-12 |
2017-01-24 |
Kendra Baldwin |
Wearable wrist inhaler
|
DK3212212T3
(da)
|
2014-10-31 |
2020-12-21 |
Univ Monash |
Pulverformulering
|
EP3244952A4
(fr)
|
2015-01-14 |
2018-11-14 |
Respira Therapeutics, Inc. |
Procédés et dispositifs de dispersion de poudre
|
GB201503720D0
(en)
|
2015-03-05 |
2015-04-22 |
Glaxosmithkline Ip No 2 Ltd |
Chemical compound
|
TW201643179A
(zh)
|
2015-03-11 |
2016-12-16 |
葛蘭素史克智慧財產發展有限公司 |
Tslp結合蛋白
|
USD767114S1
(en)
|
2015-03-18 |
2016-09-20 |
Amneal Pharmaceuticals Company Gmbh |
Inhalation device
|
USD769439S1
(en)
|
2015-03-18 |
2016-10-18 |
Amneal Pharmaceuticals Company Gmbh |
Inhalation device
|
GB201504689D0
(en)
|
2015-03-19 |
2015-05-06 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
WO2016161830A1
(fr)
*
|
2015-04-09 |
2016-10-13 |
正大天晴药业集团股份有限公司 |
Bande de libération de médicament
|
CN106139335B
(zh)
*
|
2015-04-09 |
2022-12-16 |
正大天晴药业集团股份有限公司 |
一种药粉释放装置
|
TWI597079B
(zh)
*
|
2015-04-10 |
2017-09-01 |
微劑量醫療公司 |
泡殼帶進給機構
|
MA41938A
(fr)
|
2015-04-21 |
2018-02-28 |
Almirall Sa |
Dérivés hétérocycliques amino-substitués utilisés comme inhibiteurs des canaux sodiques
|
AU364719S
(en)
|
2015-05-20 |
2015-10-14 |
Korea United Pharm Inc |
Medicine inhaler
|
RS65562B1
(sr)
|
2015-06-15 |
2024-06-28 |
Glaxosmithkline Ip Dev Ltd |
Nrf2 regulatori
|
CN107709306A
(zh)
|
2015-06-15 |
2018-02-16 |
葛兰素史密斯克莱知识产权发展有限公司 |
Nrf2调节剂
|
JP6786527B2
(ja)
|
2015-06-15 |
2020-11-18 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2レギュレーター
|
WO2016202800A1
(fr)
|
2015-06-16 |
2016-12-22 |
Almirall, S.A. |
Dérivés de pyrrolotriazinone en tant qu'inhibiteurs de pi3k
|
CN107614037B
(zh)
*
|
2015-07-29 |
2021-09-03 |
正大天晴药业集团股份有限公司 |
药物释放带
|
UY36851A
(es)
|
2015-08-16 |
2017-03-31 |
Glaxosmithkline Ip Dev Ltd |
Compuestos para uso en aplicaciones antibacterianas
|
KR20180052762A
(ko)
|
2015-09-22 |
2018-05-18 |
글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 |
브로모도메인 억제제로서 사용하기 위한 피리디논 디카르복스아미드
|
US10364256B2
(en)
|
2015-10-06 |
2019-07-30 |
Glaxosmithkline Intellectual Property Development Limited |
Biaryl pyrazoles as NRF2 regulators
|
WO2017060855A1
(fr)
|
2015-10-06 |
2017-04-13 |
Glaxosmithkline Intellectual Property Development Limited |
Pyrazoles d'arylcyclohéxyle utilisés en tant que régulateurs de nrf2
|
WO2017085692A1
(fr)
|
2015-11-18 |
2017-05-26 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Compositions pharmaceutiques à base de ribavirine
|
GB201604680D0
(en)
|
2016-03-21 |
2016-05-04 |
Glaxosmithkline Ip Dev Ltd |
Chemical Compounds
|
EP3440075B1
(fr)
|
2016-04-07 |
2020-01-29 |
GlaxoSmithKline Intellectual Property (No. 2) Limited |
Benzo[b]furanes en tant qu'inhibiteurs de bromodomaine
|
EP3440069B1
(fr)
|
2016-04-07 |
2020-10-28 |
GlaxoSmithKline Intellectual Property (No. 2) Limited |
Dérivés de pyridyle en tant qu'inhibiteurs de bromodomaines
|
WO2017176291A1
(fr)
*
|
2016-04-08 |
2017-10-12 |
Kendra Baldwin T |
Inhalateur de poignet portable
|
US10844015B2
(en)
|
2016-05-24 |
2020-11-24 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
Pyridine dicarboxamide derivatives as bromodomain inhibitors
|
GB201614940D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Chemical compounds
|
GB201614934D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Chemical compounds
|
GB201614939D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Ip Dev Ltd |
Crystalline hydrate
|
WO2018055526A1
(fr)
|
2016-09-20 |
2018-03-29 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Antagonistes de trpv4
|
EP3515889A1
(fr)
|
2016-09-20 |
2019-07-31 |
GlaxoSmithKline Intellectual Property (No. 2) Limited |
Antagonistes de trpv4
|
TW201825458A
(zh)
|
2016-09-20 |
2018-07-16 |
英商葛蘭素史克智慧財產(第二)有限公司 |
Trpv4拮抗劑
|
CN109045427B
(zh)
*
|
2016-10-03 |
2021-06-25 |
捷普科技(上海)有限公司 |
药剂分配器
|
WO2018094392A1
(fr)
|
2016-11-21 |
2018-05-24 |
Lupin Inc. |
Distributeur de médicament
|
WO2018104766A1
(fr)
|
2016-12-06 |
2018-06-14 |
Glaxosmithkline Intellectual Property Development Limited |
Dérivés d'acide propanoïque 3-(2,3-dihydro-1h-inden-5-yl) et leur utilisation en tant que régulateurs de nrf2
|
JP2020500919A
(ja)
|
2016-12-12 |
2020-01-16 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2レギュレーターとしての3−カルボン酸ピロール
|
WO2018109642A1
(fr)
|
2016-12-12 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
N-aryl pyrazoles en tant que régulateurs de nrf2
|
ES2848699T3
(es)
|
2016-12-14 |
2021-08-11 |
Glaxosmithkline Ip Dev Ltd |
Compuestos de 3-oxo-1,4-diazepinilo como activadores de NRF2
|
WO2018109647A1
(fr)
|
2016-12-14 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
Bisaryle amides en tant que régulateurs de nrf2
|
US11117905B2
(en)
|
2016-12-14 |
2021-09-14 |
Glaxosmithkline Intellectual Property Development Limited |
Bisaryl heterocycles as NRF2 activators
|
EP3555104B1
(fr)
|
2016-12-15 |
2021-11-24 |
GlaxoSmithKline Intellectual Property Development Limited |
Composés nrf2
|
EP3555082B1
(fr)
|
2016-12-15 |
2022-01-26 |
GlaxoSmithKline Intellectual Property Development Limited |
Triazoles à liaison éther utilisés en tant que régulateurs de nrf2
|
US10702495B2
(en)
|
2017-02-20 |
2020-07-07 |
Nexien Biopharma, Inc. |
Method and compositions for treating dystrophies and myotonia
|
GB201703282D0
(en)
|
2017-03-01 |
2017-04-12 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Compounds
|
CN108622469B
(zh)
*
|
2017-03-24 |
2023-08-15 |
李和伟 |
一种独立包装的履带式给药器
|
US11167022B2
(en)
|
2017-03-31 |
2021-11-09 |
Glaxosmithkline Intellectual Property Development Limited |
Immunogenic composition, use and method of treatment
|
SG11201909478UA
(en)
|
2017-04-24 |
2019-11-28 |
Cocrystal Pharma Inc |
Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication
|
AU2018308199B2
(en)
|
2017-07-25 |
2023-08-31 |
Adherium (Nz) Limited |
Adherence monitoring method and device
|
TW201919682A
(zh)
|
2017-08-08 |
2019-06-01 |
西班牙商阿爾米雷爾有限公司 |
活化Nrf2路徑的新穎化合物
|
GB201716369D0
(en)
|
2017-10-06 |
2017-11-22 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Compounds
|
GB201716392D0
(en)
|
2017-10-06 |
2017-11-22 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Compounds
|
US20210177861A1
(en)
|
2017-12-11 |
2021-06-17 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
WO2019116231A1
(fr)
|
2017-12-11 |
2019-06-20 |
Glaxosmithkline Intellectual Property Development Limited |
Activateur de nrf2 pour le traitement d'une lésion pulmonaire aiguë, d'un syndrome de détresse respiratoire aiguë et d'un syndrome de dysfonction d'organes multiples
|
GB201720989D0
(en)
|
2017-12-15 |
2018-01-31 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
BR112020014431A2
(pt)
|
2018-01-17 |
2020-12-01 |
Glaxosmithkline Intellectual Property Development Limited |
inibidores de pl4kiiibeta
|
CN110237373B
(zh)
*
|
2018-03-08 |
2023-06-02 |
润生药业有限公司 |
一种生产用于联合用药的药物载体的装置及方法
|
US20210085897A1
(en)
|
2018-04-06 |
2021-03-25 |
Lupin Inc. |
Medicament dispenser
|
EP3796906A1
(fr)
|
2018-05-23 |
2021-03-31 |
GlaxoSmithKline Intellectual Property Management Limited |
Indanes utilisés en tant qu'activateurs de nrf2
|
MX2021000917A
(es)
|
2018-07-27 |
2021-06-23 |
Cocrystal Pharma Inc |
Derivados de pirrolo[2,3-b]piridina como inhibidores de la replicación del virus de la gripe.
|
GB201812671D0
(en)
|
2018-08-03 |
2018-09-19 |
Coalesce Product Dev Ltd |
An inhaler device
|
GB201814167D0
(en)
|
2018-08-31 |
2018-10-17 |
Glaxosmithkline Ip No 2 Ltd |
Compounds
|
NZ773698A
(en)
|
2018-09-10 |
2024-02-23 |
Cipla Ltd |
Single blister-strip based dispenser
|
JP7472108B2
(ja)
|
2018-09-10 |
2024-04-22 |
コクリスタル ファーマ,インコーポレイテッド |
ピリドピラジン系及びピリドトリアジン系インフルエンザウィルス複製阻害剤
|
MX2021004215A
(es)
|
2018-10-17 |
2021-07-15 |
Cocrystal Pharma Inc |
Combinaciones de inhibidores de la replicación del virus de la gripe.
|
AU2019380421A1
(en)
|
2018-11-13 |
2021-06-03 |
Cocrystal Pharma, Inc. |
Formulations of influenza therapeutics
|
WO2020112716A1
(fr)
|
2018-11-26 |
2020-06-04 |
Cocrystal Pharma, Inc. |
Inhibiteurs de la réplication du virus de la grippe
|
CA3138530A1
(fr)
|
2019-04-29 |
2020-11-05 |
Insmed Incorporated |
Compositions de poudre seche de promedicaments de treprostinil et methodes d'utilisation de celles-ci
|
EP3750528A1
(fr)
|
2019-06-11 |
2020-12-16 |
Nexien Biopharma, Inc. |
Compositions pour le traitement de dystrophies et de la myotonie
|
GB201908536D0
(en)
|
2019-06-13 |
2019-07-31 |
Glaxosmithkline Ip Dev Ltd |
Compounds
|
EP4114743A1
(fr)
|
2020-03-06 |
2023-01-11 |
Vectura Delivery Devices Limited |
Procédé de fabrication d'une bande alvéolée pour inhalateur de poudre sèche
|
US20230151034A1
(en)
|
2020-03-17 |
2023-05-18 |
Cocrystal Pharma, Inc. |
Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
|
CA3176877A1
(fr)
|
2020-03-25 |
2021-09-30 |
Lupin Inc. |
Distributeurs de medicaments a plusieurs supports
|
AU2021254045A1
(en)
|
2020-04-10 |
2022-10-13 |
Cocrystal Pharma, Inc. |
Inhibitors of norovirus and coronavirus replication
|
WO2021216547A1
(fr)
|
2020-04-20 |
2021-10-28 |
Sorrento Therapeutics, Inc. |
Administration pulmonaire de polypeptides ace2
|
EP4061457A1
(fr)
|
2020-06-15 |
2022-09-28 |
Norton (Waterford) Limited |
Emballage blister et inhalateur le comprenant
|
PL244222B1
(pl)
|
2020-09-24 |
2023-12-18 |
Polfarmex Spolka Akcyjna |
Inhalator do podawania leku
|
PL244221B1
(pl)
|
2020-09-24 |
2023-12-18 |
Polfarmex Spolka Akcyjna |
Inhalator do podawania leku
|
WO2022175425A1
(fr)
|
2021-02-22 |
2022-08-25 |
Glaxosmithkline Intellectual Property Development Limited |
Inhibiteurs de la kinase mtor inhalés destinés à être utilisés dans le traitement ou la prévention d'une infection par un virus respiratoire à arn
|
JP2024510717A
(ja)
|
2021-02-22 |
2024-03-11 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
免疫原性組成物、使用及び方法
|
WO2022179967A1
(fr)
|
2021-02-23 |
2022-09-01 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Vadadustat pour le traitement de la covid-19 chez un sujet hospitalisé
|
TW202321196A
(zh)
|
2021-08-03 |
2023-06-01 |
美商共結晶製藥公司 |
冠狀病毒抑制劑
|
KR20240045294A
(ko)
|
2021-08-13 |
2024-04-05 |
노턴 (워터포드) 리미티드 |
건조 분말 약제 흡입기
|
GB202111658D0
(en)
|
2021-08-13 |
2021-09-29 |
Norton Waterford Ltd |
Dry powder medicament inhaler
|
WO2023052476A1
(fr)
|
2021-09-29 |
2023-04-06 |
Norton (Waterford) Limited |
Inhalateur de médicament en poudre sèche
|
CA3227858A1
(fr)
|
2021-09-29 |
2023-04-06 |
Norton (Waterford) Limited |
Inhalateur de medicament en poudre seche
|
GB202113921D0
(en)
|
2021-09-29 |
2021-11-10 |
Norton Waterford Ltd |
Dry powder medicament inhaler
|
CN114178071B
(zh)
*
|
2021-12-10 |
2022-09-09 |
杭州博乐工业设计股份有限公司 |
一种可更换储液设备的喷雾器
|
WO2023150747A1
(fr)
|
2022-02-07 |
2023-08-10 |
Insmed Incorporated |
Compositions de poudre sèche de bédaquiline et de sels et leurs méthodes d'utilisation
|
GB2618145A
(en)
*
|
2022-04-29 |
2023-11-01 |
Merxin Ltd |
Manifold
|